CB-010
Showing 1 - 25 of 780
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Fullerton, California
- +192 more
Oct 17, 2022
System for the Anticipation of Challenging Behaviors
Completed
- Autism Spectrum Disorder
- Smart, non-invasive shirt - Physiological parameters
- +2 more
-
Ariel, IsraelAriel University
Dec 29, 2022
Tay-Sachs Disease Sandhoff Disease Trial in Worldwide (venglustat GZ402671, )
Active, not recruiting
- Tay-Sachs Disease Sandhoff Disease
- venglustat GZ402671
- placebo
-
Los Angeles, California
- +23 more
Jan 31, 2022
Childbirth-related Post-traumatic Stress Disorder in
Recruiting
- Post Traumatic Stress Disorder
-
Lausanne, Vaud, SwitzerlandLausanne University Hospital
May 9, 2023
Primary Hypertension Trial in Chongqing (External Ultrasonic Micro-bubble)
Not yet recruiting
- Primary Hypertension
- External Ultrasonic Micro-bubble
-
Chongqing, Chongqing, ChinaThe Second Affilated Hospital of Chongqing Medical Universty
Oct 30, 2023
Advanced Colorectal Cancer, Metastatic Colorectal Cancer Trial in Worldwide (MRTX849, Cetuximab, mFOLFOX6 Regimen)
Recruiting
- Advanced Colorectal Cancer
- Metastatic Colorectal Cancer
- MRTX849
- +3 more
-
Birmingham, Alabama
- +208 more
Aug 3, 2022
Advanced NSCLC Trial in Shanghai (GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin,
Not yet recruiting
- Advanced Non-Small Cell Lung Cancer
- GLS-012+GLS-010
- +2 more
-
Shanghai, Shanghai, ChinaShang Hai Pulmonary Hospital
Aug 3, 2023
Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- CB-011
-
New York, New York
- +3 more
Feb 15, 2023
Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Stereotactic body radiation(SBRT)
- Zimberelimab (GLS-010)
- (no location specified)
Aug 22, 2023
Malignant Tumors Trial (IMMH-010)
Enrolling by invitation
- Malignant Neoplasms
-
Guangzhou, ChinaGuangdong Provincial People's Hospital
Dec 30, 2022
Diabetic Peripheral Neuropathic Pain Trial in Southfield (CBD/PEA, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- CBD/PEA
- Placebo
-
Southfield, MichiganPure Green Pharmaceuticals Inc.
Mar 2, 2023
Postoperative Pain, Children, Only Trial in Istanbul (Regional anesthesia intervention)
Completed
- Postoperative Pain
- Children, Only
- Regional anesthesia intervention
-
Istanbul, TurkeyProf. Dr. Cemil Tascioglu City Hospital
Jan 9, 2023
Insomnia Trial in Ann Arbor (Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM), Sleep Hygiene Education (SHE-TM))
Not yet recruiting
- Insomnia
- Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
- Sleep Hygiene Education (SHE-TM)
-
Ann Arbor, MichiganUniversity of Michigan
Apr 3, 2023
Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)
Recruiting
- Multiple Myeloma
- Selinexor (80mg/d)
- +4 more
-
Zhengzhou, Henan, China
- +4 more
Aug 16, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- (no location specified)
Nov 9, 2023
Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)
Recruiting
- Classical Hodgkin Lymphoma
- Zimberelimab 240mg
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023
CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)
Not yet recruiting
- Central Nervous System Lymphoma
- Selinexor
- +2 more
-
Hefei, Anhui, China
- +4 more
Jan 26, 2023
Caudal Block and Other Methods of Postoperative Pain Relief in
Completed
- Analgesia
- +2 more
- caudal block
- +2 more
-
Manama, BahrainSalmanyia Medical Complex
Oct 10, 2023